01Core principlesThe concepts and mechanisms needed to understand the subject.
Sampling method follows both target visibility and the information required. Core biopsy preserves architecture and can provide invasion, grade and receptor information; fine-needle aspiration supplies cells and may answer selected cyst or nodal questions. Ultrasound, mammographic or MRI guidance must be the method that actually displays the lesion, with specimen radiography used to prove calcification retrieval.
The pathology label applies only to the tissue obtained. Adequacy, needle position, marker location and radiological-pathological concordance determine whether it answers the case. Suspected lymphoma is a separate architecture-dependent pathway: NICE advises considering excision biopsy first, reserving core for situations where surgical risk outweighs benefit, and offering feasible excision after a nondiagnostic core rather than simply repeating another core.
Key points
- Core biopsy removes tissue cylinders, preserving architecture needed for many breast diagnoses and often providing material for grade and receptor testing.
- Fine-needle aspiration yields cells rather than tissue architecture; it can answer selected cyst or nodal questions but an inadequate aspirate does not exclude malignancy.
- NHS England assessment guidance states that cytology should not be used alone to make a non-operative breast-cancer diagnosis in screening assessment.
- Choose ultrasound, stereotactic, tomosynthesis or MRI guidance according to the modality that actually displays the intended target.
- For calcification, specimen imaging and marker placement help prove retrieval and enable later localisation; benign tissue without target retrieval remains discordant.
- Interpret B or C categories alongside adequacy and clinical-imaging findings, then escalate B3, inadequate or discordant results through lesion-specific multidisciplinary review.
- When non-Hodgkin lymphoma is suspected, discuss tissue with haematology and pathology: consider excision biopsy first, use core when excision risk outweighs benefit, and offer feasible excision after a nondiagnostic core.
02Mechanisms and patternsImportant relationships and how to distinguish them.
Core biopsy provides tissue structure for distinguishing invasive from in-situ processes in many settings and enables receptor testing when sufficient malignant material is present.
Fine-needle aspiration can sample cyst contents or lymph nodes and may be useful in selected pathways, but isolated cells give less architectural information than a core.
Ultrasound, stereotactic or MRI guidance should match lesion visibility; the specimen and marker position must correspond to the abnormality intended for diagnosis.
B and C categories communicate pathological certainty and adequacy, yet their clinical meaning depends on imaging suspicion, representative sampling and multidisciplinary concordance.
Cytology alone is inadequate for many lymphoma classifications. NG52 considers excision first; a core is an alternative when operative risk outweighs benefit and must be handled for the anticipated studies.
03Interpreting evidenceInformation, measurements and their limitations.
Consider the information, its meaning and its limitations before deciding what follows.
- 01
Ultrasound-guided core biopsy - Why
- Sample a visible solid mass while preserving histological architecture.
- Interpretation and limitations
- Check the needle traverses the target and specimens are adequate; bleeding risk, anticoagulants and local anaesthetic safety require individual assessment.
- 02
Stereotactic or tomosynthesis biopsy - Why
- Sample mammographic calcification or distortion without an ultrasound correlate.
- Interpretation and limitations
- Specimen radiography can confirm retrieval of calcification, and a marker supports later localisation; absence of the target makes a benign result unreliable.
- 03
Fine-needle aspiration cytology - Why
- Sample cells from selected nodes, cysts or lesions where cytology answers the question.
- Interpretation and limitations
- Inadequate or indeterminate cytology does not exclude malignancy, and cytology alone should not provide a non-operative cancer diagnosis in screening assessment.
- 04
Histology-imaging correlation - Why
- Decide whether the pathological diagnosis explains lesion morphology.
- Interpretation and limitations
- A B2 benign result may be concordant for a classic benign target yet discordant for spiculation; B3 lesions require lesion-specific multidisciplinary management.
- 05
Suspected lymphoma tissue pathway - Why
- Preserve enough architecture and viable material for accurate lymphoma diagnosis and classification.
- Interpretation and limitations
- Consider excision biopsy first. If surgical risk favours core, obtain adequate large-calibre cores with pathology coordination; after a nondiagnostic core, offer feasible excision rather than another core.
04Applied reasoningWorked examples connecting principles to decisions.
01Worked case: integrated breast assessmentApply core biopsy, fine-needle aspiration and cytology to a defined presentationMammography shows clustered pleomorphic calcification without an ultrasound correlate. A freehand fine-needle aspirate yields scant benign ductal cells.+
- 1Identify that calcification, rather than a palpable mass, is the target and select mammographic image guidance capable of proving that the sampled material contains it.
- 2Arrange stereotactic or tomosynthesis-guided tissue sampling with specimen radiography, using core or vacuum-assisted technique according to the assessment protocol.
- 3Treat the scant benign cytology as non-diagnostic for the suspicious calcification because it neither preserves architecture nor demonstrates target retrieval.
- 4Review histology, calcification retrieval and post-biopsy marker position together, escalating repeat or surgical sampling if the result remains discordant.
- 5Verify that pathology has adequate material for the required classification and that the patient receives one integrated result rather than competing test reports.
02Sampling selectionChoose tissue method by lesion visibilityAn abnormality requires pathological diagnosis, but it is not visible on every imaging modality.+
- 1Name the diagnostic requirement: distinguish solid lesion histology, sample a suspicious node, retrieve calcification or assess a skin or nipple process.
- 2Use the guidance method that shows the abnormality in real time or stereotactic coordinates, rather than choosing the quickest needle technique.
- 3Plan specimen handling before biopsy. For suspected lymphoma, coordinate with haematology and pathology, consider excision first, and use adequate core only when surgical risk outweighs the benefit of excision; retain calcification radiography, receptor testing or microbiology for their relevant targets.
- 4Review adequacy, target retrieval and complication advice immediately, then link the pathology report back to the intended lesion.
03Discordant sample pathwayDo not let a target miss become reassurancePost-procedure review suggests that benign tissue came from beside rather than within the suspicious lesion.+
- 1Retain the original imaging concern and document why the specimen is non-representative, including needle position or absent calcification in the cores.
- 2Discuss a repeat image-guided approach capable of reaching the target, such as stereotactic or vacuum-assisted sampling for mammographic-only disease.
- 3Explain to the patient that benign tissue was found but does not yet account for the abnormal image; avoid describing the overall result simply as benign.
- 4Verify repeat pathology and images are reconciled at the multidisciplinary meeting before discharge or treatment planning.
05Checking understandingVerify the reasoning, revisit uncertainties and apply feedback.
- Check puncture-site bleeding and provide advice on compression, bruising, infection symptoms and when anticoagulant management should be revisited.
- For calcification biopsy, document whether specimen radiography demonstrated the target and whether the marker lies at the sampled site.
- Track inadequate, indeterminate and B3 diagnoses to the specified repeat biopsy, vacuum-assisted excision or surgical decision.
- Ensure receptor or ancillary test sufficiency is reviewed before treatment discussion when malignant tissue is found.
06Special situationsVariants, exceptions and circumstances that change the usual approach.
More tissue is not always more representative
A larger sample taken from the wrong coordinates remains non-diagnostic. Target verification matters at least as much as needle gauge or number of cores.
Cyst aspiration has a separate purpose
Aspiration may relieve a symptomatic simple cyst and confirm fluid, but a residual mass, bloody aspirate or suspicious imaging needs further assessment rather than repeated blind drainage.
Lymphoma changes the tissue plan
Core preserves more architecture than cytology, but NG52 still advises considering excision first for suspected non-Hodgkin lymphoma. If a risk-justified core is nondiagnostic, offer feasible excision rather than simply repeating core.
Categories are communications tools
B1 to B5 and C1 to C5 convey adequacy and diagnostic concern within their sampling systems. They do not independently prove imaging-pathology concordance.
07Common pitfallsFrequent interpretation and management errors.
- 01
Using fine-needle cytology alone to establish a non-operative screening cancer diagnosis omits tissue architecture and conflicts with current NHS England guidance.
- 02
Calling scant normal tissue benign when the target was missed converts an inadequate procedure into false reassurance.
- 03
Sampling a mammographic-only lesion freehand under ultrasound cannot demonstrate that the intended abnormality entered the specimen.
- 04
Stopping after a B3 result without lesion-specific multidisciplinary planning ignores heterogeneous upgrade risk and incomplete sampling.
- 05
Treating core as the automatic first procedure for suspected lymphoma overlooks NG52 preference for excision and risks another inadequate sample when a nondiagnostic core is merely repeated.